back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-08 17:27 Tx date 2024-03-04 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,666
+16,666 vol $1.00 each |
247,485 | |
| Filed 2024-03-08 17:21 Tx date 2024-03-04 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-16,666
-16,666 vol $1.00 each |
20,000 | |
| Filed 2024-03-06 11:38 Tx date 2024-03-06 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,600
+24,000 vol $0.40 each |
254,819 | |
| Filed 2024-01-13 15:48 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,482
+11,666 vol $1.07 each |
202,819 | |
| Filed 2024-01-13 15:47 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-12,482.62
-11,666 vol $1.07 each |
71,666 | |
| Filed 2023-11-18 15:28 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,200
+5,000 vol $1.04 each |
191,153 | |
| Filed 2023-11-18 15:27 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-5,200
-5,000 vol $1.04 each |
83,332 | |
| Filed 2023-09-15 17:49 Tx date 2023-09-12 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+108,000 vol |
144,000 | |
| Filed 2023-05-03 13:23 Tx date 2023-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,999
+16,666 vol $0.54 each |
186,153 | |
| Filed 2023-05-03 13:22 Tx date 2023-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-8,999.64
-16,666 vol $0.54 each |
88,332 | |
| Filed 2023-03-06 12:18 Tx date 2023-03-03 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,500
+16,667 vol $0.51 each |
169,487 | |
| Filed 2023-03-06 12:17 Tx date 2023-03-03 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-8,500.17
-16,667 vol $0.51 each |
104,998 | |
| Filed 2023-01-14 15:44 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,883
+11,667 vol $0.59 each |
152,820 | |
| Filed 2023-01-14 15:44 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-6,883.53
-11,667 vol $0.59 each |
121,665 | |
| Filed 2022-11-19 12:05 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,400
+5,000 vol $0.48 each |
127,623 | |
| Filed 2022-11-19 12:04 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-2,400
-5,000 vol $0.48 each |
133,332 | |
| Filed 2022-11-19 12:00 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+36,000 vol |
36,000 | |
| Filed 2022-11-19 11:58 Tx date 2020-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-16 20:05 Tx date 2022-11-16 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,897
+13,530 vol $0.362 each |
136,153 | |
| Filed 2022-08-19 14:12 Tx date 2022-08-16 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,716
+3,300 vol $0.52 each |
122,623 | |
| Filed 2022-08-19 14:11 Tx date 2022-08-16 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,384
+8,120 vol $0.54 each |
119,323 | |
| Filed 2022-08-19 14:09 Tx date 2022-08-16 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,335
+8,500 vol $0.51 each |
111,203 | |
| Filed 2022-05-05 11:55 Tx date 2022-05-02 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+16,667 vol |
102,703 | |
| Filed 2022-05-05 11:54 Tx date 2022-05-02 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-16,667 vol |
138,332 | |
| Filed 2022-03-07 14:33 Tx date 2022-03-03 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+16,667 vol |
86,036 | |
| Filed 2022-03-07 14:32 Tx date 2022-03-03 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-16,667 vol |
154,999 | |
| Filed 2022-01-13 13:45 Tx date 2022-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+11,667 vol |
69,369 | |
| Filed 2022-01-13 13:44 Tx date 2022-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-11,667 vol |
171,666 | |
| Filed 2021-11-19 20:42 Tx date 2021-11-15 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+30,000 vol |
183,333 | |
| Filed 2021-11-01 19:37 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,999
+13,888 vol $0.72 each |
57,702 | |
| Filed 2021-10-13 22:22 Tx date 2021-05-03 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+16,667 vol |
26,471 | |
| Filed 2021-10-13 22:21 Tx date 2021-05-03 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-16,667 vol |
153,333 | |
| Filed 2021-10-13 22:19 Tx date 2021-03-03 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+50,000 vol |
170,000 | |
| Filed 2021-08-05 18:10 Tx date 2021-08-05 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,864
+17,343 vol $0.86 each |
27,147 | |
| Filed 2021-01-15 18:49 Tx date 2021-01-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+70,000 vol |
120,000 | |
| Filed 2020-12-17 18:31 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-450,000 vol |
50,000 | |
| Filed 2020-12-17 18:30 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-88,235 vol |
9,804 | |
| Filed 2020-09-25 20:05 Tx date 2020-09-24 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,333
+98,039 vol $0.34 each |
98,039 | |
| Filed 2020-06-15 13:03 Tx date 2020-06-11 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+500,000 vol |
500,000 | |
| Filed 2020-05-19 21:32 Tx date 2020-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-19 21:32 Tx date 2020-05-01 |
$ATE
Antibe Therapeutics Inc. |
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|